Lung Cancer Resource Center

Lung Cancer

Checkpoint Inhibitors Plus Cell Therapy for NSCLC Reduces Tumor Progression

Adoptive cell therapy in combination with checkpoint inhibitors may be promising new treatment for patients with non-small cell lung cancer (NSCLC), according to a...
hematology oncology news cancer news

Hem/Onc Roundup: Statins May Improve Breast Cancer Survival, Clotting Risk During Chemo

Each week on DocWire News, editors bring you the latest news and research in hematology and oncology. Here are this week’s top headlines: World Lung...
Lung Cancer

World Lung Cancer Day: Education, Advocacy, and Remembrance

August 1 is World Lung Cancer Day—a day where patients, physicians, and cancer organizations around the globe educate about prevention, commemorate lives lost, and...
Ringing the Ceremonial “Cancer Bell” Following a Course of Treatment May Have Unintended Consequences on Patients

Melanoma, Lung Cancer Death Has Declined in the U.S.

A new report found an overall decrease in mortality due to cancer across men and women and all racial/ethnic groups between 2001 and 2018. The...
hematology oncology news cancer news

Hem/Onc Roundup: Black Women with Breast Cancer Have Double the Mortality Risk of White...

A new study from researchers at the University of Central Florida found the gap in breast cancer survival rates between Black and white women...

Patients with Primary Lung Cancers Detected by LDCT at Reduced Risk of Brain Metasases

A new study shows that patients with primary lung cancer detected using low-dose computed tomography (LDCT) screening have a lower risk of the cancer...
Phase 2 KEYNOTE-799 Trial: Pembrolizumab Plus cCRT Safe, Effective in NSCLC

Phase 2 KEYNOTE-799 Trial: Pembrolizumab Plus cCRT Safe, Effective in NSCLC

Treatment with pembrolizumab plus concurrent chemoradiation therapy (cCRT) was safe and effective in patients with locally advanced, stage III non–small cell lung cancer (NSCLC),...

Curated Journal Reading List